Residual cancer at radical cystectomy with or without neoadjuvant chemotherapy: a pathological stage-matched comparison

Leilei Xia; J Everett Knudsen; Daniel S Roberson; Erika L Wood; Anosh Dadabhoy; Sofia Romano; Thomas J Guzzo; Trinity J Bivalacqua; Siamak Daneshmand

doi:10.1111/bju.16529

Residual cancer at radical cystectomy with or without neoadjuvant chemotherapy: a pathological stage-matched comparison

BJU Int. 2025 Jan;135(1):59-62. doi: 10.1111/bju.16529. Epub 2024 Oct 1.

Authors

Leilei Xia¹, J Everett Knudsen¹, Daniel S Roberson², Erika L Wood¹, Anosh Dadabhoy¹, Sofia Romano¹, Thomas J Guzzo², Trinity J Bivalacqua², Siamak Daneshmand¹

Affiliations

¹ Department of Urology, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA.
² Division of Urology, Department of Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.

PMID: 39353865
DOI: 10.1111/bju.16529

No abstract available

Keywords: bladder cancer; immunotherapy; muscle invasive; neoadjuvant chemotherapy; outcomes; radical cystectomy; residual cancer; urothelial cancer.